All News Avicanna Inc.

Equities

AVCN

CA05368K1003

Delayed Toronto S.E. Other stock markets 08:01:24 16/05/2024 pm IST			5-day change	1st Jan Change
0.36 ^CAD	-1.37%		+14.29%	+2.86%

14/05	Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	MT
14/05	Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	14/05	MT
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	14/05	MT
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023	14/05	MT
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter	14/05	AQ
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa	13/05	MT
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa	13/05	MT
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa	13/05	AQ
Avicanna Raises About $2.1 Million in Non-brokered Private Placement	19/04	MT
Avicanna Announces Closing of Non-brokered Private Placement	19/04	AQ
Avicanna Inc. announced that it has received CAD 2.125584 million in funding	18/04	CI
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study	10/04	AQ
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study	10/04	CI
Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024	02/04
Avicanna's Q4 Loss Narrows, Revenue Grows	02/04	MT
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022	02/04	MT
Avicanna Reports Full Year 2023 Audited Financial Results	02/04	AQ
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	MT
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	27/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Avicanna Inc.

Equities

AVCN

CA05368K1003

All News

Filters